Rui-Nan Zhang1, Rui-Dan Zheng2, Yu-Qiang Mi3, Da Zhou1, Feng Shen1, Guang-Yu Chen1, Chan-Yan Zhu1, Qin Pan4, Jian-Gao Fan5. 1. Department of Gastroenterology and Center for Fatty Liver, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China. 2. Department of Hepatology, Zhengxing Hospital, Zhangzhou, 363000, China. 3. Department of Infective Disease, Tianjin Infectious Disease Hospital, Tianjin, 300192, China. 4. Department of Gastroenterology and Center for Fatty Liver, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China. pan_qin@yeah.net. 5. Department of Gastroenterology and Center for Fatty Liver, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China. fanjiangao@gmail.com.
Abstract
BACKGROUND AND AIM: The association between nonalcoholic fatty liver disease (NAFLD) and apolipoprotein C3 gene (APOC3) promoter region single-nucleotide polymorphisms (SNPs) rs2854117 and rs2854116 is controversial. The aim of this study was to investigate the relationship between other polymorphisms of APOC3 and NAFLD in Chinese. METHODS: Fifty-nine liver biopsy-proven NAFLD patients and 72 healthy control subjects were recruited to a cohort representing Chinese Han population. The polymorphisms in the exons and flanking regions of APOC3 and patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs738409 polymorphisms were genotyped. RESULTS: Among the five SNPs (rs4225, rs4520, rs5128, rs2070666, and rs2070667) in APOC3, only rs2070666 (c.179 + 62 T/A) was significantly different in genotype and allele frequency (both p < 0.01) between groups of NAFLD and control. After adjusting for sex, age, serum triglycerides, total cholesterol, body mass index, and the PNPLA3 rs738409 polymorphism, the APOC3 rs2070666 A allele was an independent risk factor for NAFLD with an odds ratio (OR) of 3.683 and 95 % confidence interval (CI) of 1.037-13.084. The APOC3 rs2070666 A allele was linked to the fourth quartile of the controlled attenuation parameter values (OR 2.769, 95 % CI 1.002-7.651) in 131 subjects, and also linked to the significant histological steatosis (OR 4.986, 95 % CI 1.020-24.371), but neither to liver stiffness measurement values nor to hepatic histological activity and fibrosis in NAFLD patients. CONCLUSIONS: The APOC3 rs2070666 A allele is a risk factor for NAFLD independent of obesity, dyslipidemia, and PNPLA3 rs738409, and it might contribute to increased liver fat content in Chinese Han population.
BACKGROUND AND AIM: The association between nonalcoholic fatty liver disease (NAFLD) and apolipoprotein C3 gene (APOC3) promoter region single-nucleotide polymorphisms (SNPs) rs2854117 and rs2854116 is controversial. The aim of this study was to investigate the relationship between other polymorphisms of APOC3 and NAFLD in Chinese. METHODS: Fifty-nine liver biopsy-proven NAFLD patients and 72 healthy control subjects were recruited to a cohort representing Chinese Han population. The polymorphisms in the exons and flanking regions of APOC3 and patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs738409 polymorphisms were genotyped. RESULTS: Among the five SNPs (rs4225, rs4520, rs5128, rs2070666, and rs2070667) in APOC3, only rs2070666 (c.179 + 62 T/A) was significantly different in genotype and allele frequency (both p < 0.01) between groups of NAFLD and control. After adjusting for sex, age, serum triglycerides, total cholesterol, body mass index, and the PNPLA3rs738409 polymorphism, the APOC3rs2070666 A allele was an independent risk factor for NAFLD with an odds ratio (OR) of 3.683 and 95 % confidence interval (CI) of 1.037-13.084. The APOC3rs2070666 A allele was linked to the fourth quartile of the controlled attenuation parameter values (OR 2.769, 95 % CI 1.002-7.651) in 131 subjects, and also linked to the significant histological steatosis (OR 4.986, 95 % CI 1.020-24.371), but neither to liver stiffness measurement values nor to hepatic histological activity and fibrosis in NAFLD patients. CONCLUSIONS: The APOC3rs2070666 A allele is a risk factor for NAFLD independent of obesity, dyslipidemia, and PNPLA3rs738409, and it might contribute to increased liver fat content in Chinese Han population.
Authors: M Sasso; I Tengher-Barna; M Ziol; V Miette; C Fournier; L Sandrin; R Poupon; A-C Cardoso; P Marcellin; C Douvin; V de Ledinghen; J-C Trinchet; M Beaugrand Journal: J Viral Hepat Date: 2011-10-13 Impact factor: 3.728
Authors: Donna M Lehman; Dong-Jing Fu; Angela B Freeman; Kelly J Hunt; Robin J Leach; Teresa Johnson-Pais; Jeanette Hamlington; Thomas D Dyer; Rector Arya; Hanna Abboud; Harald H H Göring; Ravindranath Duggirala; John Blangero; Robert J Konrad; Michael P Stern Journal: Diabetes Date: 2005-04 Impact factor: 9.461
Authors: Ghia Euskirchen; Thomas E Royce; Paul Bertone; Rebecca Martone; John L Rinn; F Kenneth Nelson; Fred Sayward; Nicholas M Luscombe; Perry Miller; Mark Gerstein; Sherman Weissman; Michael Snyder Journal: Mol Cell Biol Date: 2004-05 Impact factor: 4.272
Authors: M van Hoek; T W van Herpt; A Dehghan; A Hofman; A G Lieverse; C M van Duijn; J C M Witteman; E J G Sijbrands Journal: Diabetologia Date: 2011-03-04 Impact factor: 10.122